EBC - ON DEMAND
European Bifurcation Club 2012 – EBC 2012 – Castelldefels, Spain
BIOSENSORS
The Axxess Stent: from concept to long term clinical evidence
Author: Andrejs Erglis, MD Riga
CONCLUSION
- The Axxess dedicated Biolimus A9 eluting bifurcation stent is easy to deploy once steps are understood
- High procedural success rates with 99% delivery > 99 % angiographic success
- Delivers over 1 wire, does not need to rotate or align with SB
- SB protected
- “Carina sparing”
- The safety and efficacy of the Axxess Biolimus A9-eluting stent was confirmed up to 4 years
- The DIVERGE study demonstrated excellent results: all-cause cumulative MACE rate 18.5%
- Ischemia-driven TLR rate 10.6%
- very late definite stent thrombosis 1.0%